Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome–lysosome fusion in dystrophin‐deficient mdx mice
Acta Physiologica · 2025
DOI: 10.1111/apha.14243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2025. Verfasst von Akanksha Agrawal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Mice, Inbred mdx, Microtubules, Autophagosomes, Histone Deacetylase 6. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, Mrs. Clifford Elder White Graham Endowed Research Fund.
Abstract (Originalsprache)
Aim
Duchenne muscular dystrophy is a progressive muscle‐wasting disease caused by mutations in the dystrophin gene. Despite progress in dystrophin‐targeted gene therapies, it is still a fatal disease requiring novel therapeutics that can be used synergistically or alternatively to emerging gene therapy. Defective autophagy and disorganized microtubule networks contribute to dystrophic pathogenesis, yet the mechanisms by which microtubule alterations regulate autophagy remain elusive. The present study was designed to uncover possible mechanisms underpinning the role of microtubules in regulating autophagy in dystrophic mice.
Methods
Mdx mice were also supplemented with Tubastatin A, a pharmacological inhibitor of histone deacetylase 6, and pathophysiology was assessed. Mdx mice with a genetic deletion of the Nox‐2 scaffolding subunit p47 phox were used to assess redox dependence on tubulin acetylation.
Results
Our data show decreased acetylation of α‐tubulin with enhanced histone deacetylase 6 expression. Tubastatin A increases tubulin acetylation and Q‐SNARE complex formation but does not alter microtubule organization or density, indicating improved autophagosome–lysosome fusion. Tubastatin A increases the acetylation of peroxiredoxin and protects it from hyper‐oxidation, hence modulating intracellular redox status in mdx mice. Tubastatin A reduces muscle damage and enhances force production. Genetic down regulation of Nox2 activity in the mdx mice promotes autophagosome maturation but not autolysosome formation.
Conclusion
Our data highlight that autophagy is differentially regulated by redox and acetylation in mdx mice. By improving autophagy through promoting tubulin acetylation, Tubastatin A decreases the dystrophic phenotype and improves muscle function, suggesting a great potential for clinical translation and treating dystrophic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: George G Rodney
Förderung
- NIAMS NIH HHS
- NIH HHS
- Mrs. Clifford Elder White Graham Endowed Research Fund
- National Institutes of Health
Zitieren
APA
Agrawal, A., Clayton, E. L., Cavazos, C. L., Clayton, B. A., & Rodney, G. G. (2025). Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome–lysosome fusion in dystrophin‐deficient mdx mice. Acta Physiologica. https://doi.org/10.1111/apha.14243
Vancouver
Agrawal A, Clayton EL, Cavazos CL, Clayton BA, Rodney GG. Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome–lysosome fusion in dystrophin‐deficient mdx mice. Acta Physiologica. 2025. doi:10.1111/apha.14243
BibTeX
@article{Agrawal2025,
author = {Agrawal, Akanksha and Clayton, Erin L and Cavazos, Courtney L and Clayton, Benjamin A and Rodney, George G},
title = {Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome–lysosome fusion in dystrophin‐deficient mdx mice},
journal = {Acta Physiologica},
year = {2025},
doi = {10.1111/apha.14243}
}
EUVIMED